register

News & Trends - Biotechnology

Viertel Foundation awards $4.1M to medical research

Health Industry Hub | November 22, 2019 |

The prestigious annual Viertel Senior Medical Research Fellowships have been announced for 2019 committing just over $3.75 million to three mid-career Australian researchers undertaking leading edge research into immunology and infectious diseases, as well as its role of the immune microenvironment in cancer.

The 2019 Senior Medical Research Fellows are:

1.     Professor Andrew Steer – Murdoch Children’s Research Institute

2.     Dr Tracy Putoczki – Walter and Eliza Hall Institute of Medical Research

3.     Dr Richard Berry – Monash Biomedicine Discovery Institute.

Each Fellow receives $1.25 million ($250,000 per year for five years) to support their important work informing the development of new therapies in their areas of specialisation. 

 “Medical research, and many innovations to advance our community, social, economic and health wellbeing, rely on philanthropy. For nearly 25 years Sylvia and Charles Viertel’s legacy has been honoured through the fellowships and the establishment of an impressive alumni of medical researchers,” said Jodi Kennedy, General Manager of Charitable Trusts and Philanthropy, Equity Trustees.

“The Sylvia and Charles Viertel Charitable Foundation funds two of the Fellowships. We were delighted this year to bring together the Viertel funding with additional funds from two other charitable trusts we manage, the Cross Family Trust and the Frank Alexander Charitable Trust, to make a third fellowship possible,” she said.

In addition, five $85,000 one-year clinical investigation scholarships were awarded to:

1.     Dr Jun Yang – Hudson Institute of Medical Research

2.     Dr Amali Mallawaarachchi – The Garvan Institute of Medical Research

3.     Dr Nidhi Garg – The University of Sydney

4.     Dr Mastura Monif – Monash University

5.     Dr Andrew Neal – Monash University.

Professor Peter Leedman, Chairman of the Viertel Foundation’s Medical Advisory Board, revealed that the 2019 applications for both the Fellowships and the clinical investigations scholarships, were of an extremely high standard.

You may also like Where credibility and trust go, clinicians follow. Download whitepaper.

“Each year we are impressed by the quality of the candidates and the incredible work they are doing in pursuit of new diagnostics, treatments and preventative strategies for some of our most intractable medical problems,” said Professor Leedman.

The Viertel Foundation is managed in partnership with co-trustees Justice Debra Mullins AO (Chair), Rex Freudenberg and Paul de Silva, and is one of Australia’s largest charitable foundations distributing around $7.5 million annually.

Click the link for more about the Sylvia and Charles Viertel Charitable Foundation.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


Medical and Science

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

Health Industry Hub | September 6, 2024 |

Medical & Science: NACCHO has announced the recipients of the 2024 Aboriginal and Torres Strait Islander Pharmacy Leadership Grant: Jes […]

More


ESG

First report exposes glaring gaps in healthcare sector sustainability

First report exposes glaring gaps in healthcare sector sustainability

Health Industry Hub | September 6, 2024 |

ESG: The first comprehensive report outlining sustainability and decarbonisation efforts in the Australian healthcare sector has been released, aimed at […]

More


News & Trends - Pharmaceuticals

Expanded access to Shingrix is a start: 'We need reform for all current and future vaccines'

Expanded access to Shingrix is a start: ‘We need reform for all current and future vaccines’

Health Industry Hub | September 6, 2024 |

Pharma News: Access to GSK’s Shingrix vaccine, following the 2023-24 federal budget decision, has been limited to “immunocompromised patients aged […]

More


News & Trends - Pharmaceuticals

NSW government fails to back mental health inquiry findings with essential funding

NSW government fails to back mental health inquiry findings with essential funding

Health Industry Hub | September 6, 2024 |

NSW Government has support for 24 of 39 recommendations from the Portfolio Committee’s Inquiry Report on ‘Equity, accessibility and appropriate […]

More


This content is copyright protected. Please subscribe to gain access.